{
  "docId": "019de075-e061-72f9-baa2-90171b05eced",
  "docSlug": "cdaaa50efb264b4a4093f665bafb20a4",
  "documentTitle": "Absci | Investor Presentation Deck | 111 slides",
  "authorId": "absci",
  "authorName": "Absci",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 80,
  "pageCount": 111,
  "prevPage": 79,
  "nextPage": 81,
  "slideType": "before_after",
  "function": "illustrate_case",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a split-screen layout to contrast project objectives with results.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/80",
  "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced",
  "deckJsonHref": "/decks/019de075-e061-72f9-baa2-90171b05eced.json",
  "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-80",
  "components": [
    {
      "bbox": {
        "h": 0.4,
        "w": 0.35,
        "x": 0.06,
        "y": 0.34
      },
      "kind": "list",
      "text": "Test 'zero shot' model by designing HCDR3 and HCDR123 for HER2 binding. Assess multiple parameters: Binding rates, Sequence diversity, Immunogenicity, Functionality, Developability.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "baa290eb-a24b-4038-b97e-7b6cbec66229",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.5,
        "x": 0.42,
        "y": 0.34
      },
      "kind": "list",
      "text": "1. Delivers diverse, novel, high affinity binders. 2. Maintains high level of specificity. 3. Outperforms biological baseline. 4. Enables multi-dimensional lead optimization: Desired cross-species reactivity, Optimal developability, Higher potency than Trastuzumab.",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "de52a873-0bc5-4021-8c0a-f7fc793e4d38",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "AI de novo design of HER2 antibodies",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a2642070-736d-4dd8-a20e-8b0e0696f91d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.42,
        "y": 0.25
      },
      "kind": "title",
      "text": "Outcome of AI-guided antibody drug creation",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3fcc547f-2cb8-466e-97d6-7a6d549ca086",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.3,
        "x": 0.06,
        "y": 0.25
      },
      "kind": "title",
      "text": "Case study goals",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "895bb1b8-23f0-4c5a-936b-03e2707503d5",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "before-after-framing",
      "slug": null,
      "matchId": "e9c79097-3adc-4747-b915-a2f4c6b80e5a",
      "evidence": "The slide explicitly contrasts 'Case study goals' with 'Outcome of AI-guided antibody drug creation'.",
      "confidence": 0.95
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}